AstraZeneca climbs on heart-drug study
May 11, 2009 at 04:39 AM EDT
Shares of AstraZeneca rise as Anglo-Swedish company says late-stage trial shows a heart drug worked better than a competing medication from Bristol-Myers Squibb and Sanofi-Aventis.